Personalized Medicine – News and Features

Researchers uncover new insights into the molecular mechanisms of ADAR1, a protein that regulates RNA-induced immune responses. Their findings could open new pathways for treating autoimmune diseases and enhancing cancer immunotherapy.

This article explores 6-base genome sequencing and how it is empowering researchers to expand their studies to include both genetic and epigenetic data. 

A person’s “bioenergetic age”, or how youthfully their cells generate energy, might be a key indicator of whether they’re at risk of developing Alzheimer’s disease, new research from Weill Cornell Medicine shows.

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study led by Weill Cornell Medicine investigators.

Thomas Moehring highlights how advanced technologies such as mass spectrometry, automation and AI are accelerating biomarker discovery and clinical applications, leading to breakthroughs in diagnostics and therapies for complex diseases.

A new approach to monitoring molecular processes deep in tissues could accelerate personalized medicine, cancer diagnostics and disease detection.

Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine, which they hope to repurpose as a cancer treatment.

Next-generation proteomics is enabling researchers to explore the proteome with unprecedented depth and scale. This article will explore recent advances in the application of high-throughput proteomics in precision medicine.

Scientists develop a synthetic microbiome therapy to fight C. difficile infections offering a safer, targeted alternative to fecal transplants.

Researchers found that prenatal infections followed by early social stress can lead to anxiety-like behaviors and brain dysfunction. Changes in microglia and cerebellar neurons were linked to psychiatric symptoms.